The University of Chicago Header Logo

Seiko Diane Yamada

Concepts (382)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
35
2025
829
2.940
Why?
Endometrial Neoplasms
16
2018
243
1.400
Why?
Peritoneal Neoplasms
11
2016
196
1.170
Why?
Antineoplastic Combined Chemotherapy Protocols
12
2025
2666
0.990
Why?
Metformin
2
2025
134
0.860
Why?
Fallopian Tube Neoplasms
7
2016
39
0.840
Why?
Uterine Neoplasms
5
2019
289
0.700
Why?
MAP Kinase Kinase 4
5
2012
61
0.630
Why?
Genital Neoplasms, Female
4
2016
118
0.630
Why?
Neoplasms, Glandular and Epithelial
3
2017
81
0.570
Why?
Intestinal Obstruction
1
2019
99
0.550
Why?
Neoplasm Recurrence, Local
10
2019
1538
0.440
Why?
Female
67
2025
51997
0.400
Why?
Neoplasm Metastasis
12
2019
1102
0.380
Why?
Omentum
7
2018
69
0.370
Why?
Carcinosarcoma
1
2012
31
0.360
Why?
Antineoplastic Agents, Hormonal
2
2012
161
0.350
Why?
Tamoxifen
1
2012
177
0.340
Why?
Aged
36
2025
21986
0.330
Why?
Carcinoma, Endometrioid
3
2018
60
0.330
Why?
Middle Aged
39
2025
29642
0.330
Why?
MAP Kinase Signaling System
5
2018
212
0.330
Why?
Aged, 80 and over
22
2022
7461
0.300
Why?
Cystadenocarcinoma, Serous
4
2016
69
0.300
Why?
Neoplasm Staging
13
2025
2087
0.290
Why?
Humans
69
2025
98799
0.280
Why?
Uterine Cervical Neoplasms
7
2012
326
0.280
Why?
Ovariectomy
4
2014
98
0.280
Why?
Adult
33
2025
29698
0.280
Why?
Epithelial Cells
4
2017
710
0.270
Why?
Cancer-Associated Fibroblasts
2
2019
45
0.270
Why?
Posterior Leukoencephalopathy Syndrome
1
2008
14
0.270
Why?
Mitogen-Activated Protein Kinase Kinases
2
2012
100
0.270
Why?
Biomarkers, Tumor
5
2014
1786
0.270
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2006
12
0.250
Why?
Proteomics
2
2019
282
0.240
Why?
MAP Kinase Kinase 6
1
2006
10
0.240
Why?
Fallopian Tubes
2
2017
49
0.230
Why?
Chylous Ascites
1
2005
9
0.230
Why?
Retroperitoneal Neoplasms
1
2005
42
0.220
Why?
Sarcoma
2
2006
222
0.220
Why?
Hyperlipidemias
2
2016
93
0.220
Why?
Tumor Cells, Cultured
8
2016
1029
0.220
Why?
Teratoma
1
2005
57
0.220
Why?
Disease-Free Survival
9
2015
1196
0.210
Why?
Cytoreduction Surgical Procedures
1
2025
105
0.210
Why?
Adipocytes
2
2018
181
0.200
Why?
Cisplatin
9
2016
578
0.200
Why?
Carcinoma, Small Cell
1
2004
116
0.200
Why?
Paclitaxel
5
2012
484
0.190
Why?
Adenocarcinoma, Clear Cell
6
2012
64
0.190
Why?
Genes, Tumor Suppressor
1
2002
156
0.180
Why?
Double-Blind Method
2
2025
1793
0.180
Why?
Neoplasm Grading
2
2015
425
0.180
Why?
Radiotherapy, Conformal
4
2003
88
0.170
Why?
Mice, Nude
9
2018
829
0.170
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2016
406
0.170
Why?
Retrospective Studies
13
2019
11104
0.170
Why?
Neoadjuvant Therapy
1
2025
477
0.170
Why?
Neoplasm Invasiveness
10
2014
583
0.160
Why?
Cancer Survivors
1
2022
110
0.160
Why?
Cell Line, Tumor
8
2019
2913
0.160
Why?
Sexual Behavior
2
2015
343
0.150
Why?
Hysterectomy
8
2018
175
0.150
Why?
Glycolysis
2
2018
198
0.150
Why?
Infusions, Intravenous
5
2012
403
0.150
Why?
Nicotinamide N-Methyltransferase
1
2019
10
0.150
Why?
RNA, Small Interfering
3
2016
573
0.140
Why?
DNA-Binding Proteins
3
2018
1275
0.140
Why?
Gene Expression Regulation, Neoplastic
5
2018
1400
0.140
Why?
Glycogen
1
2018
58
0.140
Why?
Mice
15
2018
12762
0.140
Why?
Antibodies, Monoclonal, Humanized
3
2013
1105
0.140
Why?
CD36 Antigens
1
2018
15
0.130
Why?
Prognosis
8
2019
4139
0.130
Why?
Cohort Studies
5
2017
3242
0.130
Why?
DNA Repair Enzymes
1
2018
65
0.130
Why?
Coculture Techniques
5
2018
175
0.130
Why?
Proto-Oncogene Proteins c-met
2
2011
199
0.130
Why?
Combined Modality Therapy
7
2006
1754
0.130
Why?
Immunohistochemistry
5
2018
1818
0.130
Why?
Drug Resistance, Neoplasm
2
2018
671
0.130
Why?
Cell Adhesion
7
2014
421
0.120
Why?
Antigens, Neoplasm
1
2018
366
0.120
Why?
Carboplatin
3
2012
331
0.120
Why?
Radiotherapy, Adjuvant
5
2004
325
0.120
Why?
Caryophyllaceae
1
2005
1
0.110
Why?
Basidiomycota
1
2005
9
0.110
Why?
Siderophores
1
2005
21
0.110
Why?
BRCA1 Protein
1
2017
222
0.110
Why?
Nanomedicine
1
2015
19
0.110
Why?
Cadherins
2
2008
189
0.110
Why?
Venous Thromboembolism
1
2017
178
0.110
Why?
Animals
17
2018
29045
0.110
Why?
Neoplasms, Unknown Primary
1
2014
13
0.110
Why?
Polymers
1
2016
224
0.110
Why?
Drug Delivery Systems
1
2016
202
0.100
Why?
Treatment Outcome
10
2019
9806
0.100
Why?
Pelvic Neoplasms
3
2004
43
0.100
Why?
Vinblastine
2
2004
84
0.100
Why?
Fibronectins
1
2014
104
0.100
Why?
Population Surveillance
1
2015
218
0.100
Why?
Diffusion Magnetic Resonance Imaging
1
2016
305
0.100
Why?
Nanoparticles
1
2016
219
0.100
Why?
Sex Cord-Gonadal Stromal Tumors
1
2013
19
0.100
Why?
Piperazines
1
2005
308
0.100
Why?
Neoplasm Transplantation
3
2011
400
0.090
Why?
Sequence Analysis, DNA
1
2016
920
0.090
Why?
Adenocarcinoma
5
2004
1215
0.090
Why?
Infusions, Parenteral
2
2011
47
0.090
Why?
Receptor, IGF Type 1
1
2012
45
0.090
Why?
Survival Analysis
3
2012
1530
0.090
Why?
Tissue Array Analysis
1
2012
135
0.090
Why?
Ustilago
1
2002
3
0.090
Why?
Benzimidazoles
1
2012
120
0.090
Why?
Angiogenesis Inhibitors
1
2013
281
0.090
Why?
Ascites
1
2011
55
0.090
Why?
Cystadenocarcinoma, Papillary
4
2004
9
0.090
Why?
Disease Progression
4
2019
1621
0.090
Why?
Sirolimus
1
2012
181
0.080
Why?
Anoikis
1
2011
7
0.080
Why?
Kaplan-Meier Estimate
4
2018
909
0.080
Why?
Anilides
1
2011
50
0.080
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2011
82
0.080
Why?
DNA Transposable Elements
1
2002
171
0.080
Why?
Receptors, Urokinase Plasminogen Activator
1
2010
20
0.080
Why?
Follow-Up Studies
5
2012
4049
0.080
Why?
Extracellular Matrix
2
2014
261
0.080
Why?
TOR Serine-Threonine Kinases
1
2012
224
0.080
Why?
Quinolines
1
2011
97
0.080
Why?
Viral Tail Proteins
1
2010
3
0.080
Why?
Hepatocyte Growth Factor
1
2010
86
0.080
Why?
Bacteriophage mu
1
2010
17
0.080
Why?
Xenograft Model Antitumor Assays
4
2016
559
0.080
Why?
Recombinant Fusion Proteins
1
2011
557
0.080
Why?
Vascular Endothelial Growth Factor A
1
2011
402
0.080
Why?
Integrin alphaVbeta3
1
2009
16
0.080
Why?
Prospective Studies
2
2016
4837
0.080
Why?
Receptor Protein-Tyrosine Kinases
1
2010
160
0.080
Why?
Chemoradiotherapy
1
2012
337
0.070
Why?
Needs Assessment
1
2010
174
0.070
Why?
Antineoplastic Agents
5
2018
2386
0.070
Why?
Dual Specificity Phosphatase 1
1
2009
17
0.070
Why?
Mutation
6
2017
4443
0.070
Why?
Tissue Culture Techniques
1
2009
81
0.070
Why?
Hypoglycemic Agents
1
2012
416
0.070
Why?
Integrin alpha5
1
2008
5
0.070
Why?
Breast Neoplasms
2
2014
3303
0.070
Why?
Mitogen-Activated Protein Kinase 8
1
2008
21
0.070
Why?
Recombinant Proteins
1
2010
994
0.070
Why?
Gene Expression Profiling
2
2012
1572
0.070
Why?
Fibroblasts
2
2009
767
0.070
Why?
Immediate-Early Proteins
1
2009
160
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
76
0.070
Why?
Chemotherapy, Adjuvant
4
2003
527
0.070
Why?
Coagulation Protein Disorders
1
2007
2
0.070
Why?
Vaginitis
1
2007
3
0.070
Why?
Apoptosis
4
2010
1754
0.070
Why?
Brachytherapy
5
2012
139
0.060
Why?
Plasminogen
1
2007
45
0.060
Why?
Bevacizumab
3
2013
255
0.060
Why?
Diabetes Mellitus, Type 2
2
2012
1293
0.060
Why?
Escherichia coli
1
2010
572
0.060
Why?
Dexamethasone
1
2009
318
0.060
Why?
Cell Proliferation
4
2018
1801
0.060
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2006
27
0.060
Why?
Glucocorticoids
1
2009
371
0.060
Why?
Proto-Oncogene Proteins c-kit
1
2006
80
0.060
Why?
Cells, Cultured
3
2019
2859
0.060
Why?
MAP Kinase Kinase 7
1
2006
10
0.060
Why?
Neoplasms
2
2015
3382
0.060
Why?
Hematologic Diseases
1
2006
77
0.060
Why?
Doxorubicin
2
2004
285
0.060
Why?
Cell Division
2
2008
690
0.060
Why?
Basic-Leucine Zipper Transcription Factors
1
2006
51
0.060
Why?
Carcinoma
1
2009
442
0.060
Why?
Carcinoma, Squamous Cell
1
2012
1107
0.060
Why?
Mice, SCID
1
2006
278
0.060
Why?
Clitoris
1
2005
3
0.060
Why?
Down-Regulation
2
2006
529
0.050
Why?
Tumor Suppressor Proteins
2
2008
318
0.050
Why?
Up-Regulation
3
2018
742
0.050
Why?
Sexual Dysfunctions, Psychological
1
2005
38
0.050
Why?
Transplantation, Heterologous
1
2006
375
0.050
Why?
Chicago
4
2016
1520
0.050
Why?
Bone Marrow
1
2006
419
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2006
200
0.050
Why?
Sexual Dysfunction, Physiological
1
2005
77
0.050
Why?
Physical Therapy Modalities
1
2005
92
0.050
Why?
Transcription Factors
3
2006
1724
0.050
Why?
Blotting, Western
3
2012
779
0.050
Why?
Bleomycin
1
2004
102
0.050
Why?
DNA Methylation
2
2019
735
0.050
Why?
Cell Cycle
3
2011
519
0.050
Why?
Etoposide
1
2004
207
0.050
Why?
Cyclophosphamide
1
2004
285
0.050
Why?
Cross-Sectional Studies
2
2022
2077
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2006
310
0.050
Why?
Blood
1
2002
68
0.050
Why?
Rhabdomyosarcoma, Embryonal
1
2002
7
0.050
Why?
Electronics
1
2022
21
0.050
Why?
Oxidative Stress
1
2006
490
0.050
Why?
Repressor Proteins
1
2006
450
0.050
Why?
CA-125 Antigen
2
2014
24
0.040
Why?
alpha-Fetoproteins
1
2001
48
0.040
Why?
Enzyme Activation
1
2002
679
0.040
Why?
Young Adult
4
2018
7598
0.040
Why?
Cell Movement
2
2018
821
0.040
Why?
Lymphatic Metastasis
4
2003
519
0.040
Why?
Signal Transduction
2
2014
3642
0.040
Why?
Vaginal Neoplasms
3
2007
86
0.040
Why?
Cell Cycle Proteins
1
2002
420
0.040
Why?
S-Adenosylhomocysteine
1
2019
11
0.040
Why?
Time Factors
4
2012
5586
0.040
Why?
Patient Reported Outcome Measures
1
2022
337
0.040
Why?
Radiotherapy Dosage
3
2006
478
0.040
Why?
Imaging, Three-Dimensional
1
2003
634
0.040
Why?
S-Adenosylmethionine
1
2019
28
0.040
Why?
Feasibility Studies
2
2011
818
0.040
Why?
Membrane Proteins
1
2006
1293
0.040
Why?
Niacinamide
1
2019
105
0.040
Why?
RNA, Messenger
3
2012
2076
0.040
Why?
Quality of Life
2
2022
1904
0.040
Why?
Cell Death
2
2011
258
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
889
0.040
Why?
Phosphoprotein Phosphatases
1
2018
58
0.030
Why?
Curettage
1
2018
14
0.030
Why?
Mismatch Repair Endonuclease PMS2
1
2018
25
0.030
Why?
Survival Rate
1
2002
2057
0.030
Why?
MutL Protein Homolog 1
1
2018
36
0.030
Why?
MutS Homolog 2 Protein
1
2018
33
0.030
Why?
Life Tables
3
2003
46
0.030
Why?
DNA Mismatch Repair
1
2018
60
0.030
Why?
Integrin alpha5beta1
2
2008
11
0.030
Why?
Maximum Tolerated Dose
2
2011
265
0.030
Why?
Cell Growth Processes
2
2008
83
0.030
Why?
Radiation Dosage
2
2012
233
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1949
0.030
Why?
Cell Culture Techniques
2
2009
198
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2017
36
0.030
Why?
Histones
1
2019
365
0.030
Why?
Drug Administration Schedule
2
2011
837
0.030
Why?
Chemoprevention
1
2017
93
0.030
Why?
Radiotherapy Planning, Computer-Assisted
3
2003
215
0.030
Why?
Genomic Instability
1
2016
92
0.030
Why?
Disease Models, Animal
2
2015
2581
0.030
Why?
Tissue Distribution
1
2016
290
0.030
Why?
Aspirin
1
2017
168
0.030
Why?
Endosomes
1
2016
91
0.030
Why?
Gene Silencing
1
2016
178
0.030
Why?
Mice, Inbred BALB C
1
2018
1113
0.030
Why?
Nanostructures
1
2016
93
0.030
Why?
Crosses, Genetic
1
2005
165
0.030
Why?
Carbon Dioxide
1
2016
202
0.030
Why?
Amino Acid Sequence
1
2018
2011
0.030
Why?
Plant Diseases
1
2005
83
0.030
Why?
Sexuality
1
2015
40
0.030
Why?
Lovastatin
1
2014
28
0.030
Why?
Integrins
1
2014
83
0.030
Why?
Biopsy
1
2018
1226
0.030
Why?
Transforming Growth Factor beta1
1
2014
94
0.030
Why?
Inhibins
1
2013
33
0.020
Why?
Tumor Microenvironment
1
2018
621
0.020
Why?
Likelihood Functions
1
2014
258
0.020
Why?
Genes, BRCA2
1
2014
162
0.020
Why?
Genes, BRCA1
1
2014
191
0.020
Why?
Carcinoma, Adenosquamous
2
2004
12
0.020
Why?
Self Report
1
2015
357
0.020
Why?
Injections, Intraperitoneal
1
2012
102
0.020
Why?
Tumor Stem Cell Assay
1
2012
41
0.020
Why?
Phenotype
1
2019
2673
0.020
Why?
Nuclear Proteins
1
1996
757
0.020
Why?
Immunotherapy
1
2018
831
0.020
Why?
Taxoids
1
2012
127
0.020
Why?
ras Proteins
1
2012
137
0.020
Why?
Mice, Transgenic
2
2011
1608
0.020
Why?
Fatty Acid-Binding Proteins
1
2011
25
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2011
58
0.020
Why?
Immunoenzyme Techniques
1
2012
291
0.020
Why?
Injections, Intravenous
1
2011
215
0.020
Why?
Proto-Oncogene Proteins B-raf
1
2012
170
0.020
Why?
Proto-Oncogene Proteins p21(ras)
1
2012
186
0.020
Why?
Referral and Consultation
1
2015
419
0.020
Why?
Meiosis
1
2002
87
0.020
Why?
Bone Neoplasms
2
2004
316
0.020
Why?
Logistic Models
1
2015
1276
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2012
301
0.020
Why?
Microarray Analysis
1
2010
96
0.020
Why?
Robotic Surgical Procedures
1
2017
425
0.020
Why?
Models, Biological
2
2008
1806
0.020
Why?
Phylogeny
1
2016
1344
0.020
Why?
Glycoside Hydrolases
1
2010
14
0.020
Why?
Genomics
1
2016
914
0.020
Why?
Lipid Metabolism
1
2011
221
0.020
Why?
Clinical Trials as Topic
1
2015
1128
0.020
Why?
Tumor Burden
1
2011
330
0.020
Why?
Multivariate Analysis
1
2012
1007
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2012
700
0.020
Why?
Adolescent
2
2015
10168
0.020
Why?
Administration, Oral
1
2011
677
0.020
Why?
Survivors
1
2010
211
0.020
Why?
Patient Safety
1
2011
237
0.020
Why?
Proto-Oncogene Proteins
1
2012
687
0.020
Why?
Placebos
1
2009
210
0.020
Why?
Protein Structure, Tertiary
1
2010
733
0.020
Why?
Hemagglutinins
1
2008
22
0.020
Why?
Cattle
1
2009
398
0.020
Why?
Phosphorylation
1
2010
1148
0.020
Why?
Staining and Labeling
1
2009
161
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2008
123
0.020
Why?
Procollagen-Proline Dioxygenase
1
2007
10
0.020
Why?
Microscopy, Phase-Contrast
1
2007
28
0.020
Why?
Transgenes
1
2008
173
0.020
Why?
Keratins
1
2007
63
0.020
Why?
Carcinoma, Papillary
1
2009
166
0.020
Why?
Vimentin
1
2007
47
0.020
Why?
Protein Kinase Inhibitors
1
2011
642
0.020
Why?
Femur Head
1
2006
9
0.020
Why?
Transfection
1
2008
884
0.010
Why?
Leukopenia
1
2006
66
0.010
Why?
Lumbosacral Region
1
2006
57
0.010
Why?
Ilium
1
2006
32
0.010
Why?
Peroxidases
1
2006
33
0.010
Why?
Delivery of Health Care
1
2010
483
0.010
Why?
Postoperative Complications
1
2017
2719
0.010
Why?
beta Catenin
1
2007
269
0.010
Why?
Radiation-Sensitizing Agents
1
2006
99
0.010
Why?
Homeostasis
1
2008
474
0.010
Why?
Neutropenia
1
2006
211
0.010
Why?
Sacrum
1
2006
82
0.010
Why?
Endothelial Cells
1
2009
502
0.010
Why?
Orgasm
1
2005
9
0.010
Why?
Cell Survival
1
2007
1018
0.010
Why?
Suction
1
2005
47
0.010
Why?
Least-Squares Analysis
1
2005
50
0.010
Why?
Thrombocytopenia
1
2006
194
0.010
Why?
Genetic Predisposition to Disease
1
2014
2588
0.010
Why?
Anemia
1
2006
135
0.010
Why?
Antibodies, Monoclonal
1
2010
1422
0.010
Why?
Analysis of Variance
1
2006
890
0.010
Why?
Endoplasmic Reticulum
1
2006
258
0.010
Why?
Protein Folding
1
2006
291
0.010
Why?
Bone Marrow Diseases
1
2003
38
0.010
Why?
Risk Factors
1
2014
6295
0.010
Why?
Cystadenocarcinoma
1
2003
12
0.010
Why?
Diagnosis, Differential
1
2007
1571
0.010
Why?
Abdominal Neoplasms
1
2003
38
0.010
Why?
COP9 Signalosome Complex
1
2002
2
0.010
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2002
35
0.010
Why?
Rectum
1
2003
152
0.010
Why?
Palatine Tonsil
1
2002
34
0.010
Why?
Dose-Response Relationship, Radiation
1
2002
193
0.010
Why?
Biomarkers
1
2009
2026
0.010
Why?
Neoplasms, Multiple Primary
1
2003
100
0.010
Why?
Peptide Hydrolases
1
2002
99
0.010
Why?
Radiation Injuries
1
2003
160
0.010
Why?
Treatment Failure
1
2003
300
0.010
Why?
Saccharomyces cerevisiae
1
2006
480
0.010
Why?
Pilot Projects
1
2005
978
0.010
Why?
Proportional Hazards Models
1
2004
925
0.010
Why?
Intestine, Small
1
2003
321
0.010
Why?
Urinary Bladder
1
2003
263
0.010
Why?
Pelvis
1
2001
106
0.010
Why?
Lung Neoplasms
2
2004
2474
0.010
Why?
Intracellular Signaling Peptides and Proteins
1
2002
405
0.010
Why?
Radiography
1
2002
763
0.010
Why?
Risk
1
2001
662
0.010
Why?
Hepatocyte Nuclear Factor 1
1
1996
30
0.010
Why?
Hepatocyte Nuclear Factor 1-beta
1
1996
35
0.010
Why?
Restriction Mapping
1
1996
119
0.010
Why?
Chromosomes, Human, Pair 12
1
1996
64
0.010
Why?
Hepatocyte Nuclear Factor 1-alpha
1
1996
81
0.010
Why?
Cell Differentiation
1
2002
1656
0.010
Why?
Infant
1
2002
3368
0.010
Why?
Child, Preschool
1
2002
4053
0.010
Why?
Pedigree
1
1996
988
0.010
Why?
Molecular Sequence Data
1
1996
2897
0.010
Why?
Tomography, X-Ray Computed
1
2002
2680
0.010
Why?
Liver
1
1996
1231
0.010
Why?
Child
1
2002
7771
0.000
Why?
Rats
1
1996
4079
0.000
Why?
Male
2
2002
47475
0.000
Why?
Yamada's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (382)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_